The Liver Foundation funds research, informs and supports patients and their families, educates GPs, advocates for increased government funding for screening and treatment, and strives for a world free of liver disease.
Liver disease overview: What GPs need to know
Liver disease now affects up to 3 of every 10 Australian adults.This module provides an overview of liver disease and looks at what GPs need to know about assessing and managing this condition in primary care.
Metabolic-associated fatty liver disease (MAFLD)
GPs must be able to assess the severity of metabolic-associated fatty liver disease in primary care and guide their patients' future management to determine the need for referral to secondary care or management in primary care. This course will help GPs to understand the additional steps that are required to ensure that the underlying cause is determined and addressed.
Management of patients with advanced liver disease: The role of the general practitioner
Early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. This course will show GPs how to identify cirrhosis, how to prevent and manage the complications of cirrhosis, and the important role they play in the integrated care of the patient with cirrhosis.
Identifying and managing rarer liver diseases: What GPs should be aware of
GPs play an important role in the early identification, evaluation and monitoring of patients with rarer liver diseases. This module will provide an overview of the rarer liver diseases and highlight the red flags that indicate urgent specialist review or hospitalisation.
Metabolic-associated fatty liver disease clinical audit
In this clinical audit, you will conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD), calculate their risk of liver fibrosis using validated tools and decide on further management.
The rising health threat of liver disease: What GPs can do to prevent premature mortality
Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.
